Treatment compliance in chronic illness: Current situation and future perspectives

被引：31
作者：
Conthe, P. [1 ]
Marquez Contreras, E.
Aliaga Perez, A.
Barragan Garcia, B.
de Cano Martin, M. N. Fernandez [2 ]
Gonzalez Jurado, M. [3 ,4 ]
Ollero Baturone, M. [5 ]
Pinto, J. L. [6 ]
机构：
[1] Hosp Gen Univ Gregorio Maranon, Secc Med Interna, Madrid, Spain
[2] Soc Espanola Med Atenc Primaria SEMERGEN, Grp Trabajo Gest Medicamento & Seguridad Paciente, Madrid, Spain
[3] Consejo Gen Enfermeria Espana, Madrid, Spain
[4] Univ Complutense Madrid, Madrid, Spain
[5] Hosp Univ Virgen del Rocio, Unidad Clin Med Interna UCAMI, Seville, Spain
[6] Univ Pablo de Olavide, Seville, Spain
来源：
REVISTA CLINICA ESPANOLA | 2014年 / 214卷 / 06期
关键词：
Therapeutic adherence; Chronic disease; Clinical and health-social impact; Non-compliance; THERAPEUTIC COMPLIANCE; MEDICATION ADHERENCE; DRUG-THERAPY; IMPACT; HYPERTENSION;
D O I：
10.1016/j.rce.2014.03.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Long-term chronic diseases have a high mortality rate around the world, affecting both genders equally. Despite improvements in the diagnosis and treatment of various health problems, lack of treatment compliance remains an obstacle to improving health and patient quality of life, and it carries a high associated socio-healthcare cost. The objectives of this study were to develop the concept of "therapeutic adherence", which includes both pharmacological compliance as well as non-pharmacological (level of agreement and patient involvement, lifestyle changes, etc.) treatments. The study also aimed to establish the clinical and socio-health impact of non-compliance, the reasons for non-compliance, and methods and strategies to improve compliance. The results of this study support therapeutic adherence as an essential goal of the healthcare system that encompasses all stakeholders involved in patient health. (C) 2014 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码：336 / 344
页数：9
相关论文
共 34 条
  • [1] Amado Guirado E, 2012, ALA OESTE
  • [2] Antihypertensive Medication Adherence, Ambulatory Visits, and Risk of Stroke and Death
    Bailey, James E.
    Wan, Jim Y.
    Tang, Jun
    Ghani, Muhammad A.
    Cushman, William C.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2010, 25 (06) : 495 - 503
  • [3] Ethical issues of compliance/adherence in the treatment of hypertension
    Bernardini, J
    [J]. ADVANCES IN CHRONIC KIDNEY DISEASE, 2004, 11 (02) : 222 - 227
  • [4] Adherence to Medications: Insights Arising from Studies on the Unreliable Link Between Prescribed and Actual Drug Dosing Histories
    Blaschke, Terrence F.
    Osterberg, Lars
    Vrijens, Bernard
    Urquhart, John
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52, 2012, 52 : 275 - +
  • [5] Conthe P, 2007, REV ESP CARDIOL SF, V7, P57
  • [6] Conthe P, 2012, DOCUMENTO CONSENSO A
  • [7] Better compliance to antihypertensive medications reduces cardiovascular risk
    Corrao, Giovanni
    Parodi, Andrea
    Nicotra, Federica
    Zambon, Antonella
    Merlino, Luca
    Cesana, Giancarlo
    Mancia, Giuseppe
    [J]. JOURNAL OF HYPERTENSION, 2011, 29 (03) : 610 - 618
  • [8] Medication compliance and persistence: Terminology and definitions
    Cramer, Joyce A.
    Roy, Anuja
    Burrell, Anita
    Fairchild, Carol J.
    Fuldeore, Mahesh J.
    Ollendorf, Daniel A.
    Wong, Peter K.
    [J]. VALUE IN HEALTH, 2008, 11 (01) : 44 - 47
  • [9] Variations in patients' adherence to medical recommendations - A quantitative review of 50 years of research
    DiMatteo, MR
    [J]. MEDICAL CARE, 2004, 42 (03) : 200 - 209
  • [10] Medication Nonadherence in Diabetes Longitudinal effects on costs and potential cost savings from improvement
    Egede, Leonard E.
    Gebregziabher, Mulugeta
    Dismuke, Clara E.
    Lynch, Cheryl P.
    Axon, R. Neal
    Zhao, Yumin
    Mauldin, Patrick D.
    [J]. DIABETES CARE, 2012, 35 (12) : 2533 - 2539
1234